Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology
|
September 4, 2004
Beta3-integrin regulates vascular endothelial growth factor-A-dependent permeability
Stephen D Robinson, Louise E Reynolds, Lorenza Wyder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 17, 2005
The antitumor and antiangiogenic activity of vascular endothelial growth factor receptor inhibition is potentiated by ErbB1 blockade
Patrizia Sini, Lorenza Wyder, Christian Schnell, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
April 3, 2008
An Adam15 amplification loop promotes vascular endothelial growth factor-induced ocular neovascularization
Bing Xie, Jikui Shen, Aling Dong, et al.
Journal of Medicinal Chemistry
|
November 11, 2014
Discovery and optimization of 4,5-diarylisoxazoles as potent dual inhibitors of pyruvate dehydrogenase kinase and heat shock protein 90
Tao Meng, Dadong Zhang, Zuoquan Xie, et al.
Nature Medicine
|
January 12, 2002
Enhanced pathological angiogenesis in mice lacking beta3 integrin or beta3 and beta5 integrins
Louise E Reynolds, Lorenza Wyder, Julie C Lively, et al.
Journal of Biomolecular Screening
|
August 20, 2013
An isogenic cell panel identifies compounds that inhibit proliferation of mTOR-pathway addicted cells by different mechanisms
Lorenza Wyder Peters, Klaus D Molle, Anke Thiemeyer, et al.
Angiogenesis
|
November 3, 2011
Reduced pathological angiogenesis and tumor growth in mice lacking GPR4, a proton sensing receptor
Lorenza Wyder, Thomas Suply, Bérangère Ricoux, et al.
Cancer Research
|
January 7, 2006
Antagonism of sphingosine-1-phosphate receptors by FTY720 inhibits angiogenesis and tumor vascularization
Kenneth LaMontagne, Amanda Littlewood-Evans, Christian Schnell, et al.
Chemmedchem
|
April 7, 2025
Discovery of Novel Aminopyrimidines as Selective EP2 Receptor Antagonists
Isabelle Lyothier, Stefan Diethelm, Julien Pothier, et al.
Chemmedchem
|
April 7, 2025
Discovery of ACT-1002-4271 as a Dual Prostaglandin E2 Receptor 2/Prostaglandin E2 Receptor 4 Antagonist with In Vivo Anti-Tumor Efficacy
Isabelle Lyothier, Stefan Diethelm, Julien Pothier, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Arteriosclerosis, Thrombosis, and Vascular Biology
|
September 4, 2004
Beta3-integrin regulates vascular endothelial growth factor-A-dependent permeability
Stephen D Robinson, Louise E Reynolds, Lorenza Wyder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 17, 2005
The antitumor and antiangiogenic activity of vascular endothelial growth factor receptor inhibition is potentiated by ErbB1 blockade
Patrizia Sini, Lorenza Wyder, Christian Schnell, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
April 3, 2008
An Adam15 amplification loop promotes vascular endothelial growth factor-induced ocular neovascularization
Bing Xie, Jikui Shen, Aling Dong, et al.
Journal of Medicinal Chemistry
|
November 11, 2014
Discovery and optimization of 4,5-diarylisoxazoles as potent dual inhibitors of pyruvate dehydrogenase kinase and heat shock protein 90
Tao Meng, Dadong Zhang, Zuoquan Xie, et al.
Nature Medicine
|
January 12, 2002
Enhanced pathological angiogenesis in mice lacking beta3 integrin or beta3 and beta5 integrins
Louise E Reynolds, Lorenza Wyder, Julie C Lively, et al.
Journal of Biomolecular Screening
|
August 20, 2013
An isogenic cell panel identifies compounds that inhibit proliferation of mTOR-pathway addicted cells by different mechanisms
Lorenza Wyder Peters, Klaus D Molle, Anke Thiemeyer, et al.
Angiogenesis
|
November 3, 2011
Reduced pathological angiogenesis and tumor growth in mice lacking GPR4, a proton sensing receptor
Lorenza Wyder, Thomas Suply, Bérangère Ricoux, et al.
Cancer Research
|
January 7, 2006
Antagonism of sphingosine-1-phosphate receptors by FTY720 inhibits angiogenesis and tumor vascularization
Kenneth LaMontagne, Amanda Littlewood-Evans, Christian Schnell, et al.
Chemmedchem
|
April 7, 2025
Discovery of Novel Aminopyrimidines as Selective EP2 Receptor Antagonists
Isabelle Lyothier, Stefan Diethelm, Julien Pothier, et al.
Chemmedchem
|
April 7, 2025
Discovery of ACT-1002-4271 as a Dual Prostaglandin E2 Receptor 2/Prostaglandin E2 Receptor 4 Antagonist with In Vivo Anti-Tumor Efficacy
Isabelle Lyothier, Stefan Diethelm, Julien Pothier, et al.
Page
of 2